Baird, A. A., et al., Br. J. Pharmacol. 100, 329-335 (1990). |
Carapeti, E A, et al., Gut 45:719-722 (1999). |
Glavind, E.B., et al., Am J. Physiol., 272(5, Pt. 1), G1075-G1082 (1997). |
Gorfine, S. R., Diseases of the Colon & Rectum, XP-002084601 “Treatment of Benign Anal Disease with Topical Nitroglycerin”, V38, No. 5, pp. 453-457 (1995). |
Goyal, R. K., et al., J. Clin. Invest., 52(2), 337-41 (1973). |
Heyden, B., et al., Neurourol. Urodyn. 14(2), 153-68 (1995). |
Rae, MG, et al., J Physiol, Jun. 1;493 ( Pt 2);517-27 (1996). |
Rattan, S., et al., American Physiological Society, G107-G112 (1992). |
Salapatek, A M, et al., Br J Pharmacol Mar.;123(6):1055-64 (1998). |
Salapaetek, A M et al., Am.. J. Physiol., 274(4, Pt. 1), C1145-C1157 (1998). |
Szilvassy, Z., et al., Pharmacol. Res. 36(2), 129-133 (1997). |
JP 10-1441 Tendo Seiyaku KK (Tend-N), Derwent Patent Summary (1998). |
Winquist, R. J., et al. Journal of Pharmacology and Experimental Therapeutics, vol. 248, No. 1 pp. 149-156 (1989). |
Benowitz, N. L., “Antihypertensive Agents”, Basic & Clinical Pharmacol., Edited by Katzung, Appleton & Lange, pp. 161-162, 1995. |
Boushey, H. A., “Bronchodilators & Other Agents Used in Asthma”, Basic & Clinical Pharmacol., Edited by Katzung, Appleton & Lange, pp. 310-314, 1995. |
Sharp, F. R., “Patient Selection and Treatment Modalities for Chronic Anal Fissure”, Am. J. Surg., vol. 171, No. 5, pp. 512-515, 1996. |
Kubota, et al., “Membrane properties and the neuro-effector . . . ”, Nov. 1998, J. Smooth Muscle Res., vol. 34, pp. 173-184. |
Bouvier, et al., “Nervous control of the internal anal sphincter . . . ”, Dec. 1981, J. Phisiol., vol. 310, pp. 457-469. |
Yamato, et al., “Role of Alpha adrenocepters in opossum internal anal . . . ”, abstract, J. Clin. Invest., 1990, vol. 86(2), pp. 424-429. |
T. Morita, et al., “Characterization of Functional Beta-Adrenoceptor Subtypes in Rabbit Urinary Bladder Smooth Muscle,” Tohoku L. exp. Med., (Aug. 1986), vol. 149, pp. 389-395. |
P. J. Silver, et al., “Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5,”, Eur. J. Pharmacol., (May 22, 1998), 349(2-3):263-268. |
F. S. P. Regadas, et al., “Pharmacological Study of the internal anal sphincter in patients with chronic anal fissure,” Br. J. Surg., (Jun. 1993), vol. 80, pp. 799-801. |
J. Pitt, et al., “The Role of Alpha and Beta adrenoceptors in chronic fissure-in-ano,” Program Guide and Abstracts of The American Society of Colon and Rectal Surgeons, (May 1999), p. C65. |
J. G. Hardman, et al., “Drugs Used in the Treatment of Asthma,” Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, NY, (1996), pp. 672-682. |
M. Li, et al., “Minoxidil-Induced Hair Growth is Mediated by Adenosine in Cultured Dermal Papilla Cells: Possible Involvement of Sulfonylurea Receptor 2B as a Target of Minoxidil,” The Journal of Investigative Dermatology, vol. 117, No. 6, (2002), pp. 1594-1600. |
A. Crema, et al., “Purine receptors in the guinea-pig international anal sphincter,” Br. J. Pharmac., vol. 78, (1983), pp. 599-603. |
S. Chakder and S. Rattan, “Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NO,” The American Physiological Society, (1993), pp. G702-G707. |
G. Burnstock, et al., “A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species,” Br. J. Pharmac., vol. 46, (1972), pp. 234-242. |
I. Biaggioni, et al., “Caffeine and Theophylline as Adenosine Receptor Antagonists in Humans,” The Journal of Pharmacology and Experimental Therapeutics, vol. 258, No. 2, (1991), pp. 588-593. |
D. E. Burleigh, “Non-cholinergic, non-adrenergic inhibitory neurons in human internal anal sphincter muscle,” J. Pharm, Pharmacol., vol. 35, (1983), pp. 258-260. |
R. B. Meyer and J. P. Miller, “Minireview, Analogs of Cyclic AMP and Cylic GMP: General Methods of Synthesis and the Relationship of Structure to Enzymic Activity,” Life Sciences, vol. 14, (1974), pp. 1019-1040. |
B. Heesen and J. De Mey, “Effects of cyclic AMP-affecting agents on contractile reactivity of isolated mesenteric and renal resistance arteries of the rat,” Br. Pharmacol., vol. 101, (1990), pp. 859-1040. |
S. Rattan and R. Shah, “Influence of purinoceptors' agonists and antagonists on opossum internal anal sphincter,” The American Physiological Society, (1988), pp. G389-394. |
S. Mirzazadeh, “Cyclic Nucleotide Content of the Rat Anococcygeus During Relaxations Induced by Drugs or by Non-adrenergic, Non-cholinergic Field Stimulation,” J. Pharm. Pharmacol., (1991), vol. 43, pp. 247-257. |
B. Frencker and T. Ihre, “Influence of autonomic nerves on the internal anal sphincter in man,” Gut, vol. 17, (1976), pp. 306-312. |
A. Fujita, et al., “Activation of ATP-sensitive K+ channels by ADP and K+ channel openers; homology model of sulfonylurea receptor carboxyl-termini,” Nippon Yakurigaku Zasshi, vol. 118, (Sep. 2001), pp. 177-86. |